CHRS
Coherus Oncology, Inc. Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:59:53 PM EST
0.52USD-2.971%(-0.02)4,306,287
Pre-marketNov 13, 2026 8:47:30 AM EST
0.53USD-1.578%(-0.01)
After-hoursNov 13, 2026 4:00:30 PM EST
0.5255USD+0.574%(+0.003)
CHRS Financials
In Q3 FY 2026 (ended ), Coherus Oncology, Inc. Common Stock (CHRS) reported revenue of $14.27M, net income of −$39.33M, operating cash flow of −$34.02M, and assets of $171.1M (filed ).
Loading business breakdowns…